RFK Jr. battles growing GOP frustration over vaccine policiesnews2025-09-04T19:03:50+00:00September 4th, 2025|Endpoints News|
J&J, Bristol Myers lose appeals cases challenging Medicare price negotiationnews2025-09-04T18:29:54+00:00September 4th, 2025|Endpoints News|
AstraZeneca ends manufacturing license at Indian plant as it exits the site news2025-09-04T16:16:12+00:00September 4th, 2025|Endpoints News|
AC Immune culls pipeline, lays off 30% of staff to extend cash runwaynews2025-09-04T14:07:31+00:00September 4th, 2025|Endpoints News|
Amgen, Zai Lab say stomach cancer drug’s survival benefit wanednews2025-09-03T20:17:45+00:00September 3rd, 2025|Endpoints News|
Pfizer CEO responds to Trump’s questioning of Covid datanews2025-09-03T17:50:21+00:00September 3rd, 2025|Endpoints News|
Gilead fleshes out $32B US investment plan with a new biologics facilitynews2025-09-03T17:11:11+00:00September 3rd, 2025|Endpoints News|
Novartis signs one of the year’s largest biobuck deals with Shanghai biotech Argonews2025-09-03T14:55:31+00:00September 3rd, 2025|Endpoints News|
AbbVie, AstraZeneca urge judges to toss Louisiana 340B law news2025-09-03T14:25:56+00:00September 3rd, 2025|Endpoints News|
UK government needs to improve grant process to attract more local manufacturing, trade group saysnews2025-09-03T12:47:29+00:00September 3rd, 2025|Endpoints News|